Tri Locum Partners
Latest statistics and disclosures from Tri Locum Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TEVA, AVDL, SILK, NTRA, ASND, and represent 36.63% of Tri Locum Partners's stock portfolio.
- Added to shares of these 10 stocks: SILK (+$20M), MRK (+$16M), VRTX (+$15M), BAX (+$14M), MRUS (+$13M), TNDM (+$12M), LEGN (+$10M), MDGL (+$7.4M), EXAS (+$6.2M), LYRA (+$6.1M).
- Started 13 new stock positions in CATX, INSP, MNMD, VRTX, EXAS, LYRA, BAX, MRUS, ARQT, TNDM. ALPN, SILK, MRK.
- Reduced shares in these 10 stocks: , KVUE (-$15M), GEHC (-$13M), , CTLT (-$12M), PRAX (-$8.7M), REGN (-$7.2M), VRNA (-$5.8M), AZN, SRRK.
- Sold out of its positions in ABBV, AZN, BIIB, CTLT, GEHC, KVUE, MLTX, SRRK, VRNA, IMTX.
- Tri Locum Partners was a net buyer of stock by $39M.
- Tri Locum Partners has $288M in assets under management (AUM), dropping by 31.82%.
- Central Index Key (CIK): 0001826434
Tip: Access up to 7 years of quarterly data
Positions held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 27 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 10.8 | $31M | +23% | 2.2M | 14.11 |
|
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 7.0 | $20M | +41% | 1.2M | 16.89 |
|
| Silk Road Medical Inc Common (SILK) | 6.9 | $20M | NEW | 1.1M | 18.32 |
|
| Natera (NTRA) | 6.0 | $17M | +34% | 190k | 91.46 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 5.9 | $17M | +13% | 113k | 151.17 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 5.5 | $16M | +177% | 284k | 56.09 |
|
| Merck & Co (MRK) | 5.5 | $16M | NEW | 119k | 131.95 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.2 | $15M | NEW | 36k | 418.01 |
|
| Madrigal Pharmaceuticals (MDGL) | 4.9 | $14M | +109% | 53k | 267.04 |
|
| Baxter International (BAX) | 4.7 | $14M | NEW | 318k | 42.74 |
|
| Merus N V (MRUS) | 4.5 | $13M | NEW | 286k | 45.03 |
|
| Tandem Diabetes Care Com New (TNDM) | 4.0 | $12M | NEW | 327k | 35.41 |
|
| Argenx Se Sponsored Adr (ARGX) | 3.8 | $11M | +15% | 28k | 393.72 |
|
| Xenon Pharmaceuticals (XENE) | 3.1 | $8.9M | -8% | 208k | 43.05 |
|
| Regeneron Pharmaceuticals (REGN) | 2.9 | $8.2M | -46% | 8.6k | 962.49 |
|
| Axsome Therapeutics (AXSM) | 2.8 | $8.2M | -21% | 103k | 79.80 |
|
| Praxis Precision Medicines I Com New (PRAX) | 2.3 | $6.5M | -57% | 107k | 61.02 |
|
| EXACT Sciences Corporation (EXAS) | 2.2 | $6.2M | NEW | 90k | 69.06 |
|
| Lyra Therapeutics (LYRA) | 2.1 | $6.1M | NEW | 979k | 6.22 |
|
| Astria Therapeutics (ATXS) | 1.8 | $5.2M | -31% | 370k | 14.07 |
|
| Inspire Med Sys (INSP) | 1.8 | $5.1M | NEW | 24k | 214.79 |
|
| Alpine Immune Sciences (ALPN) | 1.7 | $4.8M | NEW | 121k | 39.64 |
|
| Arcturus Therapeutics Hldg I (ARCT) | 1.6 | $4.7M | +25% | 139k | 33.77 |
|
| Arcutis Biotherapeutics (ARQT) | 1.5 | $4.5M | NEW | 450k | 9.91 |
|
| Mind Medicine Mindmed Com New (MNMD) | 1.2 | $3.6M | NEW | 380k | 9.40 |
|
| IsoRay (CATX) | 0.3 | $929k | NEW | 780k | 1.19 |
|
| Femasys (FEMY) | 0.0 | $47k | -15% | 31k | 1.55 |
|
Past Filings by Tri Locum Partners
SEC 13F filings are viewable for Tri Locum Partners going back to 2020
- Tri Locum Partners 2024 Q1 filed May 15, 2024
- Tri Locum Partners 2023 Q4 filed Feb. 14, 2024
- Tri Locum Partners 2023 Q3 filed Nov. 14, 2023
- Tri Locum Partners 2023 Q2 filed Aug. 14, 2023
- Tri Locum Partners 2023 Q1 filed May 15, 2023
- Tri Locum Partners 2022 Q4 filed Feb. 14, 2023
- Tri Locum Partners 2022 Q3 filed Nov. 14, 2022
- Tri Locum Partners 2022 Q2 filed Aug. 15, 2022
- Tri Locum Partners 2022 Q1 filed May 16, 2022
- Tri Locum Partners 2021 Q4 filed Feb. 14, 2022
- Tri Locum Partners 2021 Q3 filed Nov. 15, 2021
- Tri Locum Partners 2021 Q2 filed Aug. 16, 2021
- Tri Locum Partners 2021 Q1 filed May 17, 2021
- Tri Locum Partners 2020 Q4 filed Feb. 16, 2021